AU2019389025B2 - TYK2 inhibitors and uses thereof - Google Patents
TYK2 inhibitors and uses thereofInfo
- Publication number
- AU2019389025B2 AU2019389025B2 AU2019389025A AU2019389025A AU2019389025B2 AU 2019389025 B2 AU2019389025 B2 AU 2019389025B2 AU 2019389025 A AU2019389025 A AU 2019389025A AU 2019389025 A AU2019389025 A AU 2019389025A AU 2019389025 B2 AU2019389025 B2 AU 2019389025B2
- Authority
- AU
- Australia
- Prior art keywords
- oxygen
- sulfur
- nitrogen
- membered
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862773620P | 2018-11-30 | 2018-11-30 | |
| US62/773,620 | 2018-11-30 | ||
| PCT/US2019/063510 WO2020112937A1 (en) | 2018-11-30 | 2019-11-27 | Tyk2 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2019389025A1 AU2019389025A1 (en) | 2021-06-17 |
| AU2019389025B2 true AU2019389025B2 (en) | 2025-07-24 |
Family
ID=70848642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019389025A Active AU2019389025B2 (en) | 2018-11-30 | 2019-11-27 | TYK2 inhibitors and uses thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11053241B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3886843A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7530360B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113271938A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019389025B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3120866A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL283409B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020112937A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4327809A3 (en) | 2015-09-02 | 2024-04-17 | Takeda Pharmaceutical Company Limited | Tyk2 inhibitors and uses thereof |
| CN110300590A (zh) | 2016-10-21 | 2019-10-01 | 林伯士拉克许米公司 | Tyk2抑制剂及其用途 |
| JP7619951B2 (ja) | 2018-10-15 | 2025-01-22 | 武田薬品工業株式会社 | Tyk2阻害剤およびその使用 |
| WO2020112937A1 (en) | 2018-11-30 | 2020-06-04 | Nimbus Lakshmi, Inc. | Tyk2 inhibitors and uses thereof |
| EP4269404A4 (en) * | 2020-12-25 | 2024-12-04 | Xizang Haisco Pharmaceutical Co., Ltd. | KETOHEXOKINASE INHIBITORS AND USE THEREOF |
| EP4308556A4 (en) | 2021-03-16 | 2025-02-19 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Amino heteroaryl compounds and compositions |
| KR20240111312A (ko) | 2021-10-25 | 2024-07-16 | 카이메라 쎄라퓨틱스 인코포레이티드 | Tyk2 분해제 및 이의 용도 |
| TW202425965A (zh) * | 2022-09-30 | 2024-07-01 | 日商科研製藥股份有限公司 | 縮環化合物及含有其之醫藥 |
| CN115974751A (zh) * | 2022-12-13 | 2023-04-18 | 山东能源集团新材料有限公司 | 一种吡拉西坦制备方法及系统 |
| JP2026501940A (ja) * | 2022-12-22 | 2026-01-19 | プロテクト セラピューティクス リミテッド | ピロロピリジンおよびピロロピリダジンに基づく化合物ならびにpkr阻害剤としてのその使用 |
| EP4739694A2 (en) * | 2023-07-03 | 2026-05-13 | Blossomhill Therapeutics, Inc. | Macrocyclic compounds and use as tyk2 inhibitors |
| US11891394B1 (en) | 2023-09-06 | 2024-02-06 | King Faisal University | Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors |
| US11858935B1 (en) | 2023-09-06 | 2024-01-02 | King Faisal University | Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors |
| US11878978B1 (en) | 2023-09-06 | 2024-01-23 | King Faisal University | Pyrrolo[2,3-c]quinoline compounds as CK2 inhibitors |
| CN117342955A (zh) * | 2023-10-08 | 2024-01-05 | 盐城师范学院 | 一种制备4’-甲基-联苯-2-胺的方法 |
| WO2025222103A1 (en) * | 2024-04-19 | 2025-10-23 | Raythera, Inc. | Stat6 modulators and methods of uses thereof |
| WO2025264818A1 (en) * | 2024-06-20 | 2025-12-26 | Raythera, Inc. | Stat6 modulators and methods of uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018071794A1 (en) * | 2016-10-14 | 2018-04-19 | Nimbus Lakshmi, Inc. | Tyk2 inhibitors and uses thereof |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4709016A (en) | 1982-02-01 | 1987-11-24 | Northeastern University | Molecular analytical release tags and their use in chemical analysis |
| US5650270A (en) | 1982-02-01 | 1997-07-22 | Northeastern University | Molecular analytical release tags and their use in chemical analysis |
| US5516931A (en) | 1982-02-01 | 1996-05-14 | Northeastern University | Release tag compounds producing ketone signal groups |
| US4650750A (en) | 1982-02-01 | 1987-03-17 | Giese Roger W | Method of chemical analysis employing molecular release tag compounds |
| WO1999007703A1 (en) * | 1997-08-05 | 1999-02-18 | Pfizer Products Inc. | 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| OA12118A (en) | 1999-12-10 | 2006-05-04 | Pfizer Prod Inc | PyrroloÄ2,3-dÜpyrimidine compounds. |
| PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| KR100833371B1 (ko) | 2001-04-27 | 2008-05-28 | 젠야쿠코교가부시키가이샤 | 헤테로시클릭 화합물 및 이를 유효 성분으로 하는 항종양제 |
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| MXPA05001766A (es) | 2002-08-14 | 2005-08-19 | Atugen Ag | Uso de proteina quinasa n beta. |
| WO2004089925A1 (en) | 2003-04-03 | 2004-10-21 | Semafore Pharmaceuticals, Inc. | Pi-3 kinase inhibitor prodrugs |
| ES2382377T3 (es) | 2003-05-30 | 2012-06-07 | Gemin X Pharmaceuticals Canada Inc. | Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer |
| WO2005007623A2 (en) | 2003-07-03 | 2005-01-27 | The Trustees Of The University Of Pennsylvania | Inhibition of syk kinase expression |
| LT2612862T (lt) | 2004-05-13 | 2017-01-25 | Icos Corporation | Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai |
| DK1753764T3 (da) * | 2004-06-09 | 2009-02-16 | Glaxo Group Ltd | Pyrrolopyridin-derivater |
| JP4977465B2 (ja) * | 2004-07-28 | 2012-07-18 | 武田薬品工業株式会社 | ピロロ[2,3−c]ピリジン化合物、その製造方法および用途 |
| US7449458B2 (en) | 2005-01-19 | 2008-11-11 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| ES2493466T3 (es) | 2005-05-12 | 2014-09-11 | Abbvie Bahamas Ltd. | Promotores de la apoptosis |
| GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
| US7402325B2 (en) | 2005-07-28 | 2008-07-22 | Phoenix Biotechnology, Inc. | Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander |
| HRP20140975T1 (hr) | 2005-10-07 | 2014-11-21 | Exelixis, Inc. | Derivati n-(3-amino-hinoksalin-2-il)-sulfonamida i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze |
| WO2007053452A1 (en) | 2005-11-01 | 2007-05-10 | Targegen, Inc. | Bi-aryl meta-pyrimidine inhibitors of kinases |
| HUE028588T2 (hu) | 2005-12-13 | 2016-12-28 | Incyte Holdings Corp | Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok |
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| KR101533461B1 (ko) | 2006-04-26 | 2015-07-02 | 에프. 호프만-라 로슈 아게 | Pi3k저해제로 유용한 티에노[3,2-d]피리미딘 유도체 |
| EP2529621B1 (en) | 2006-09-22 | 2016-10-05 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
| HUE029188T2 (en) | 2007-03-12 | 2017-03-28 | Ym Biosciences Australia Pty | Phenylamino-pyrimidine compounds and their use |
| US8394794B2 (en) | 2007-03-23 | 2013-03-12 | Regents Of The University Of Minnesota | Therapeutic compounds |
| PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
| MY165582A (en) | 2008-03-11 | 2018-04-05 | Incyte Holdings Corp | Azetidine and cyclobutane derivatives as jak inhibitors |
| US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
| HRP20220766T1 (hr) | 2012-11-08 | 2022-09-16 | Bristol-Myers Squibb Company | Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora |
| EP2922841B8 (en) | 2012-11-08 | 2017-08-02 | Bristol-Myers Squibb Company | Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifn alpha responses |
| ES2702126T3 (es) | 2013-12-10 | 2019-02-27 | Bristol Myers Squibb Co | Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa |
| US9340540B2 (en) | 2014-02-28 | 2016-05-17 | Nimbus Lakshmi, Inc. | TYK2 inhibitors and uses thereof |
| WO2015168269A1 (en) * | 2014-05-01 | 2015-11-05 | Novartis Ag | Compounds and compositions as toll-like receptor 7 agonists |
| AU2017311047B2 (en) * | 2016-08-08 | 2021-07-22 | Merck Patent Gmbh | TLR7/8 antagonists and uses thereof |
| US11370794B2 (en) * | 2016-11-11 | 2022-06-28 | Dynavax Technologies Corporation | Toll-like receptor antagonist compounds and methods of use |
| WO2020112937A1 (en) | 2018-11-30 | 2020-06-04 | Nimbus Lakshmi, Inc. | Tyk2 inhibitors and uses thereof |
-
2019
- 2019-11-27 WO PCT/US2019/063510 patent/WO2020112937A1/en not_active Ceased
- 2019-11-27 CA CA3120866A patent/CA3120866A1/en active Pending
- 2019-11-27 EP EP19888308.4A patent/EP3886843A4/en active Pending
- 2019-11-27 JP JP2021530887A patent/JP7530360B2/ja active Active
- 2019-11-27 US US16/697,371 patent/US11053241B2/en active Active
- 2019-11-27 CN CN201980087661.3A patent/CN113271938A/zh active Pending
- 2019-11-27 AU AU2019389025A patent/AU2019389025B2/en active Active
-
2021
- 2021-05-14 US US17/320,394 patent/US11834449B2/en active Active
- 2021-05-24 IL IL283409A patent/IL283409B2/en unknown
-
2024
- 2024-07-26 JP JP2024120957A patent/JP2024160253A/ja active Pending
-
2025
- 2025-12-26 JP JP2025283785A patent/JP2026053668A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018071794A1 (en) * | 2016-10-14 | 2018-04-19 | Nimbus Lakshmi, Inc. | Tyk2 inhibitors and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024160253A (ja) | 2024-11-13 |
| US20200172540A1 (en) | 2020-06-04 |
| US20220106306A1 (en) | 2022-04-07 |
| AU2019389025A1 (en) | 2021-06-17 |
| WO2020112937A1 (en) | 2020-06-04 |
| EP3886843A4 (en) | 2022-08-31 |
| CA3120866A1 (en) | 2020-06-04 |
| US11053241B2 (en) | 2021-07-06 |
| IL283409A (en) | 2021-07-29 |
| CN113271938A (zh) | 2021-08-17 |
| JP2026053668A (ja) | 2026-03-25 |
| IL283409B1 (en) | 2026-03-01 |
| EP3886843A1 (en) | 2021-10-06 |
| JP2022509260A (ja) | 2022-01-20 |
| IL283409B2 (en) | 2026-07-01 |
| JP7530360B2 (ja) | 2024-08-07 |
| US11834449B2 (en) | 2023-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023237060B2 (en) | TYK2 inhibitors and uses thereof | |
| US11834449B2 (en) | TYK2 inhibitors and uses thereof | |
| EP3262049B1 (en) | Tyk2 inhibitors and uses thereof | |
| US12338242B2 (en) | TYK2 inhibitors and uses thereof | |
| AU2019360941A1 (en) | TYK2 inhibitors and uses thereof | |
| WO2023192586A1 (en) | Irak degraders and uses thereof | |
| HK40055822A (en) | Tyk2 inhibitors and uses thereof | |
| HK40055822B (en) | Tyk2 inhibitors and uses thereof | |
| HK40009936B (en) | Tyk2 inhibitors and uses thereof | |
| HK40009936A (en) | Tyk2 inhibitors and uses thereof | |
| HK1248690B (en) | Tyk2 inhibitors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED Free format text: FORMER APPLICANT(S): NIMBUS LAKSHMI, INC. |
|
| FGA | Letters patent sealed or granted (standard patent) |